02.20.25 -- They Said What? Unexpected Insights Into CDMO Selection

Two key innovations — continuous perfusion in upstream processing and multicolumn chromatography in downstream processing — are having a profound impact on biologics manufacturing.

Discover how building a product development program with a long-term vision and adopting a holistic PPQ and CPV strategy from the outset are now crucial.

Capacity constraints typically are accompanied by other challenges, including missed timelines, defect rates, and overall decreased satisfaction with pharma companies’ bioprocessing CDMOs.

Navigate the challenging path from concept to clinical reality by partnering with an experienced CDMO that can provide the expertise needed to move your therapeutic forward.

Explore innovative process and facility models that optimize efficiency, sustainability, and cost-effectiveness in biopharmaceutical manufacturing.

This research demonstrates the potential of high-pressure sterile filtration to enhance efficiency, reduce waste, and accelerate the development of innovative therapies.

A miscalculated analytical approach can be costly to develop, perform, and maintain. Many organizations also lack appropriate resources to create optimal testing methods and protocols.

Consider an integrated drug substance and drug product CMC strategy, along with technical case studies from process and analytical development that provide insight into tailored product-specific solutions.

Choosing the right host is key to creating reliable commercial processes. Review common challenges associated with the insect cell culture/baculovirus expression vector systems platform.

Learn how a leading CDMO partnered with Körber to quickly deploy a high-speed packaging solution to meet tight production deadlines in the face of a global pandemic.

Utilizing expert analytical testing services can unlock the potential of biosimilars and bring cost-effective treatments to market faster.

Join us on March 6th with Singota to explore strategies for scaling up drug development from bench to Phase 1 clinical trials. Learn how to navigate cold chain logistics, develop robust analytical methods, and avoid compromising your core values. Discover insights from Singota’s 20+ years of experience helping early-stage biopharma teams succeed. Click here to learn more.

This flyer explains the challenges SMC Ltd. was presented with when they partnered with an OEM to create an intricate atrial fibrillation vascular catheter.

Our comprehensive inspection systems, designed to adhere to the strictest regulatory standards, offer robust quality assurance, safeguarding the integrity of your product from development through to market.

Find solutions to meet your gene, protein, antibody, or cell line needs using two gene synthesis platforms that enable the design of constructs optimized for maximal expression/yield in your system.

Review PCI's commitment to environmental and social responsibility, including its ambitious sustainability goals and achievements across various categories.

Take a look at our full range of support services to streamline manufacturing processes through to commercialization of aseptic and lyophilized products.